Value of changes of tumor markers in TACE treatment of hepatocellular carcinoma / 中国介入影像与治疗学
Chinese Journal of Interventional Imaging and Therapy
;
(12): 57-60, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-862191
ABSTRACT
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. Up till now, TACE is the first choice for palliative treatment of HCC. In recent years, a series of metabolites of HCC have been found in the proteome and mRNA groups. The value of common and hot research on tumor markers in HCC for the treatment of TACE were reviewed in this article.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Interventional Imaging and Therapy
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS